Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost Inhalation in High Risk Cardiac Surgery
NCT00927654Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Jun 2009
- Primary completion
- Mar 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of iloprost in right-sided heart failure (RHF), sponsored by Ludwig Maximilian University of Munich. Started Jun 2009; status: completed.
02
Drugs
iloprost
03
Conditions
right-sided heart failure (RHF)
Beyond the preview
Go deeper on NCT00927654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927654.